http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111450237-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faae3791045bf607124481321895bb36 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 |
| filingDate | 2020-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b627945a4a01f139319b161345f0575d |
| publicationDate | 2020-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111450237-A |
| titleOfInvention | A new target for drug development for osteoporosis treatment |
| abstract | The present invention discovers the regulatory effect of TMEM16A channel protein in osteoporosis diseases, and finds new targets and methods for the diagnosis and treatment of osteoporosis, and specifically relates to the application of TMEM16A channel protein in osteoporosis treatment, especially TMEM16A A channel protein is used in the preparation of reagents or medicines for preventing or treating osteoporosis. |
| priorityDate | 2020-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 303.